Viraj A. Master

Also affiliated with Emory University Hospital

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 37 papers. Top paper: “18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial”.

18F-fluciclovine-PET/CT imaging versus conventional imaging alone to guide postprostatectomy salvage radiotherapy for prostate cancer (EMPIRE-1): a single centre, open-label, phase 2/3 randomised controlled trial

The Lancet(2021)10.1016/s0140-6736(21)00581-x

N/A

6.4DataRank · unranked

186 citations

Eduard Schreibmann, Subir Goyal, Raghuveer Halkar, Bruce Hershatter, Peter J. Rossi +14 more

Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study

The Lancet Oncology(2024)10.1016/s1470-2045(24)00211-0

N/A

1.9DataRank · unranked

86 citations

Se-Eun Kim, Viraj A. Master, David H. McDermott, Lauren C. Harshman, Suzanne Cole +40 more

Differentiation fate of a stem-like CD4 T cell controls immunity to cancer

Nature(2024)10.1038/s41586-024-08076-7

N/A

1.1DataRank · unranked

57 citations

Nataliya Prokhnevska, Ewelina Sobierajska, Petra Gregorova, Christopher B. Medina, Rajesh M. Valanparambil +9 more

Decision regret, adverse outcomes, and treatment choice in men with localized prostate cancer: Results from a multi-site randomized trial

Urologic Oncology Seminars and Original Investigations(2021)10.1016/j.urolonc.2020.11.038

N/A

1.1DataRank · unranked

21 citations

Fangxin Hong, Traci M. Blonquist, Barbara Halpenny, Niya Xiong, Christopher P. Filson +12 more

PROSPER: Phase III randomized study comparing perioperative nivolumab versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN EA8143).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps5101

N/A

0.330DataRank · unranked

8 citations

Mäneka Puligandla, Mohamad E. Allaf, David F. McDermott, Charles G. Drake, Sabina Signoretti +15 more

Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

The Oncologist(2021)10.1002/onco.13868

N/A

0DataRank · unranked

43 citations

Subir Goyal, Yuan Liu, Sean T. Evans, T. Anders Olsen, Katherine Case +14 more

Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors

The Oncologist(2021)10.1002/onco.13922

N/A

0DataRank · unranked

32 citations

Julie M. Shabto, Subir Goyal, Yuan Liu, T. Anders Olsen, Sean T. Evans +17 more

Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002851

N/A

0DataRank · unranked

30 citations

Yuan Liu, Julie M. Shabto, Dylan J. Martini, Deepak Ravindranathan, Emilie Elise Hitron +13 more

Urine-Based Metabolomics and Machine Learning Reveals Metabolites Associated with Renal Cell Carcinoma Stage

Cancers(2021)10.3390/cancers13246253

N/A

0DataRank · unranked

22 citations

David A. Gaul, Samyukta Sah, Rebecca S. Arnold, Kenneth Ogan, Viraj A. Master +6 more

Racial Differences in Clinical Outcomes for Metastatic Renal Cell Carcinoma Patients Treated With Immune-Checkpoint Blockade

Frontiers in Oncology(2021)10.3389/fonc.2021.701345

N/A

0DataRank · unranked

9 citations

Dylan J. Martini, Subir Goyal, Yuan Liu, Sean T. Evans, Benjamin Magod +12 more

Novel risk scoring system for metastatic renal cell carcinoma patients treated with cabozantinib

Cancer Treatment and Research Communications(2021)10.1016/j.ctarc.2021.100393

N/A

0DataRank · unranked

4 citations

Meredith R. Kline, Yuan Liu, Julie M. Shabto, Bradley Curtis Carthon, Greta Russler +9 more

PROSPER: Phase III RandOmized Study Comparing PERioperative nivolumab versus observation in patients with renal cell carcinoma (RCC) undergoing nephrectomy (ECOG-ACRIN EA8143).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps4596

N/A

0DataRank · unranked

10 citations

Se Eun Kim, Viraj A. Master, David F. McDermott, Sabina Signoretti, David Cella +15 more

Association of basophil to lymphocyte ratio (BLR) with clinical outcomes in metastatic hormone sensitive prostate cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e17049

N/A

0DataRank · unranked

0 citations

Limeng Wan, Yuan Liu, Jacqueline T. Brown, Greta Russler, Lauren Yantorni +7 more

CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor

Immunity(2022)10.1016/j.immuni.2022.12.002

N/A

0DataRank · unranked

350 citations

Maria A. Cardenas, Rajesh M. Valanparambil, Ewelina Sobierajska, Benjamin G. Barwick, Caroline S. Jansen +13 more

Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

The Oncologist(2022)10.1093/oncolo/oyac236

N/A

0DataRank · unranked

13 citations

Deepak Ravindranathan, Yuan Liu, Dylan J. Martini, Jacqueline T. Brown, Bassel Nazha +8 more

Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience

Journal of Immunotherapy and Precision Oncology(2022)10.36401/jipo-22-2

N/A

0DataRank · unranked

1 citations

T. Anders Olsen, Subir Goyal, Yuan Liu, Sean T. Evans, Emilie Elise Hitron +12 more

478 Real-world outcomes in patients with penile squamous cell carcinoma (pSCC) receiving immune checkpoint inhibitors (ICI)

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.0478

N/A

0DataRank · unranked

3 citations

Subir Goyal, Jacqueline Brown, Bradley Curtis Carthon, Ömer Küçük, Greta R. McClintock +5 more

Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad155

N/A

0DataRank · unranked

56 citations

Amin H. Nassar, Gregory R. Pond, Tony Zhuang, Viraj A. Master, Bassel Nazha +50 more

Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors

The Oncologist(2023)10.1093/oncolo/oyad154

N/A

0DataRank · unranked

12 citations

Julie M. Shabto, Subir Goyal, Yuan Liu, Dylan J. Martini, Bassel Nazha +13 more

Impact of 18F-Fluciclovine PET/CT Findings on Failure-Free Survival in Biochemical Recurrence of Prostate Cancer Following Salvage Radiation Therapy

Clinical Nuclear Medicine(2023)10.1097/rlu.0000000000004590

N/A

0DataRank · unranked

10 citations

Charles Marcus, David M. Schuster, Subir Goyal, Omotayo A. Adediran, Vishal R. Dhere +12 more

Association of baseline inflammatory biomarkers with outcomes in penile squamous cell carcinoma (pSCC) treated with immune checkpoint inhibitors (ICI).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.11

N/A

0DataRank · unranked

2 citations

Subir Goyal, Jacqueline T. Brown, Bradley Curtis Carthon, Ömer Küçük, Greta Russler McClintock +5 more

Core biopsy (bx) accuracy and safety of biopsy and preoperative immunotherapy in predicting histological subtype and nuclear grade in ECOG-ACRIN EA8143 perioperative nivolumab (nivo) versus observation in patients (pts) with renal cell carcinoma (RCC) undergoing nephrectomy.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.4541

N/A

0DataRank · unranked

1 citations

Se Eun Kim, David F. McDermott, Viraj A. Master, Sabina Signoretti, Mahmut Akgül +13 more

Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysis

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008011

N/A

0DataRank · unranked

32 citations

Yena Woo, Amber Draper, Caroline S. Jansen, Jennifer W. Carlisle, Pasquale F. Innominato +10 more

Differences in preoperative frailty assessment of surgical candidates by sex, age, and race

Surgery Open Science(2024)10.1016/j.sopen.2024.05.003

N/A

0DataRank · unranked

6 citations

Gregory Palmateer, Benjamin N. Schmeusser, Cameron Futral, Yuan Liu, Subir Goyal +8 more

PD‐L1 and nectin‐4 expression and genomic characterization of bladder cancer with divergent differentiation

Cancer(2024)10.1002/cncr.35465

N/A

0DataRank · unranked

6 citations

Katherine Case, Derrik Gratz, Kathryn L. Pellegrini, Elizabeth Beagle, Thomas M. Schneider +12 more

Real-World Outcomes in Patients with Advanced Penile Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Single Institution Experience

Journal of Immunotherapy and Precision Oncology(2024)10.36401/jipo-24-19

N/A

0DataRank · unranked

4 citations

Subir Goyal, Katherine Case, T. Anders Olsen, Shalini Vemuru, Ahmet Yıldırım +8 more

A missense SNP in the tumor suppressor SETD2 reduces H3K36me3 and mitotic spindle integrity in Drosophila

Genetics(2024)10.1093/genetics/iyae015

N/A

0DataRank · unranked

2 citations

Tad Manalo, Hala Zein-Sabatto, Jina Lee, Junnan Fang, Philip Chu +13 more

[18F]-Fluciclovine or [68Ga]-PSMA-11 Molecular Imaging To Guide Dose Escalation of Salvage Radiotherapy After Radical Prostatectomy for Prostate Cancer: The EMPIRE-2 Trial

European Urology(2025)10.1016/j.eururo.2025.12.003

N/A

0DataRank · unranked

6 citations

Vishal R. Dhere, Subir Goyal, Eduard Schreibmann, Pretesh Patel, Bruce Hershatter +16 more

A Spatial Metabolomics Annotation Workflow Leveraging Cyclic Ion Mobility and Machine Learning-Predicted Collision Cross Sections

Journal of the American Society for Mass Spectrometry(2025)10.1021/jasms.5c00090

N/A

0DataRank · unranked

1 citations

Eric C. Gier, Viraj A. Master, Rebecca S. Arnold, John A. Petros, Facundo M. Fernández +1 more

Exposed phosphatidylserine is a non-classical inhibitory molecule during CD8 T cell exhaustion 2323

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.250

N/A

0DataRank · unranked

0 citations

Ewelina Sobierajska, Minghao Gong, Daniel T. McManus, Maheshwor Thapa, Judong Lee +12 more

Phase 2 Study of Perioperative Lenvatinib with Pembrolizumab in Patients with Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma 3215

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.1039

N/A

0DataRank · unranked

0 citations

BaoHan T. Vo, Mehmet Asım Bilen, Yuan Liu, Amir H. Davarpanah, Bassel Nazha +16 more

Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors

Cancer Medicine(2020)10.1002/cam4.2932

N/A

0DataRank · unranked

18 citations

Dylan J. Martini, Yuan Liu, Deepak Ravindranathan, Jacqueline T. Brown, Emilie Elise Hitron +11 more

Tumor cell oxidative metabolism triggers immune escape in advanced kidney cancer 2325

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.252

N/A

0DataRank · unranked

0 citations

Christopher B. Medina, Weiwen Zhang, Maria A. Cardenas, Joshua D. Preston, Petra Foster +9 more

Association of modified Glasgow Prognostic Score (mGPS) with survival outcomes in patients with metastatic renal cell carcinoma (mRCC) treated with immune checkpoint inhibitors (CPI).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.738

N/A

0DataRank · unranked

1 citations

Yuan Liu, Dylan J. Martini, Julie M. Shabto, Elise Hitron, Greta Russler +11 more

Novel risk scoring system for metastatic renal cell carcinoma (mRCC) patients (pts) treated with cabozantinib (C).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.734

N/A

0DataRank · unranked

1 citations

Dylan J. Martini, Yuan Liu, Julie M. Shabto, Bradley Curtis Carthon, Elise Hitron +8 more

Association of baseline modified Glasgow Prognostic Score (mGPS) with survival outcomes in patients with metastatic urothelial cell carcinoma (mUCC) treated with immune checkpoint inhibitors (CPI).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.563

N/A

0DataRank · unranked

1 citations

Yuan Liu, Julie M. Shabto, Dylan J. Martini, Deepak Ravindranathan, Elise Hitron +12 more

Tumor-targeted oncolytic adenovirus demonstrates high cytotoxicity for human lung and renal cell carcinomas independently of the level of tumor PD-L1 expression.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3596

N/A

0DataRank · unranked

0 citations

Svetlana Atasheva, Cedrick Young, Viraj A. Master, Dmitry M. Shayakhmetov, Jia Yao